Related Experiment Video
Updated: Jul 20, 2026
11:29
Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
Published on: January 22, 2022
Pelvic exenteration for primary and recurrent gynaecological malignancies
Johannes H W de Wilt1, Diederik H-J van Leeuwen, Adriaan Logmans
1Department of Surgical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, P.O. Box 5201, 3008 AE Rotterdam, The Netherlands. j.h.w.dewilt@erasmusmc.nl
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|September 5, 2006
Summary
Pelvic exenteration offers a 50% long-term survival for gynaecological cancers but involves substantial post-operative morbidity. This surgical approach requires careful consideration of risks and benefits for patients with advanced or recurrent disease.
Area of Science:
- Gynaecology
- Surgical Oncology
- Oncology
Background:
- Pelvic exenteration is a radical surgical procedure for advanced or recurrent gynaecological malignancies.
- Tertiary referral centers manage complex cases requiring specialized surgical expertise.
Purpose of the Study:
- To analyze the outcomes of pelvic exenteration in gynaecological cancer patients.
- To evaluate in-hospital and long-term morbidity, disease-free survival (DFS), and overall survival (OS).
Main Methods:
- Retrospective analysis of 42 patients undergoing anterior, total, or posterior exenteration between 1991 and 2004.
- Data collected from patient files, including post-operative complications and survival rates.
- Prognostic factors for recurrence and survival were investigated.
Main Results:
- Pelvic exenteration was performed for primary (n=14) and recurrent (n=28) gynaecological cancers.
- High rates of in-hospital (45%) and late (75%) complications were observed, with significant reintervention rates (17% and 50%, respectively).
- Five-year DFS and OS were 48% and 52%, respectively. No significant prognostic factors were identified.
Conclusions:
- Pelvic exenteration can achieve long-term survival in approximately 50% of patients with gynaecological cancers.
- The procedure is associated with considerable post-operative morbidity, necessitating careful patient selection and management.
